415
Participants
Start Date
April 30, 2013
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
Placebo
Vilazodone
Viibryd
Forest Investigative Site 003, New York
Forest Investigative Site 007, New York
Forest Investigative Site 020, New York
Forest Investigative Site 027, The Bronx
Forest Investigative Site 004, Mount Kisco
Forest Investigative Site 028, Brooklyn
Forest Investigative Site 010, Brooklyn
Forest Investigative Site 002, Cedarhurst
Forest Investigative Site 037, Allentown
Forest Investigative Site 011, Media
Forest Investigative Site 012, Herndon
Forest Investigative Site 018, Decatur
Forest Investigative Site 025, Atlanta
Forest Investigative Site 035, Jacksonville
Forest Investigative Site 029, Gainesville
Forest Investigative Site 032, Orlando
Forest Investigative Site 021, West Palm Beach
Forest Investigative Site 030, Bradenton
Forest Investigative Site 023, Birmingham
Forest Investigative Site 033, Memphis
Forest Investigative Site 019, Dayton
Forest Investigative Site 022, Hoffman Estates
Forest Investigative Site 031, Dallas
Forest Investigative Site 013, Phoenix
Forest Investigative Site 015, Albuquerque
Forest Investigative Site 036, Beverly Hills
Forest Investigative Site 017, Sherman Oaks
Forest Investigative Site 034, Sherman Oaks
Forest Investigative Site 009, Oceanside
Forest Investigative Site 026, Rancho Mirage
Forest Investigative Site 001, Costa Mesa
Forest Investigative Site 008, Portland
Forest Investigative Site 016, Bellevue
Forest Investigative Site 024, Seattle
Forest Investigative Site 014, Berlin
Forest Investigative Site 005, Cherry Hill
Lead Sponsor
Forest Laboratories
INDUSTRY